The PI3K/AKT/mTOR pathway is crucial in breast cancer, as it is involved in tumor proliferation, survival, motility, metabolism and anti-tumor therapy resistance, as well as the immune response, and the activated PI3K/Akt signaling pathway is involved in poor prognosis [44]. The gene discussed is MTOR; the disease is neoplasm.